Nachrichten zur Merck & Co. Inc. Aktie

Up More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock?

It can be exciting to buy a stock that has been red hot and to jump on the bandwagon --…

Merck & Co Aktie: Keytruda bleibt wichtigstes Wachstumstreiber

New York (www.aktiencheck.de) - Merck & Co-Aktienanalyse der Citigroup: 1. Kurszielsenkung und Bewertung Citigroup hat das Kursziel für die Aktie von Merck…

Merck declares $0.81 dividend

…

Dax am Mittag weiter im Plus - Sartorius und Merck vorn

Frankfurt/Main - Der Dax hat am Dienstag nach einem etwas festeren Start seine Gewinne bis zum Mittag ausgebaut. Gegen 12:30…

DAX trotzt KI-Beben – Aixtron, Eckert, Freenet, Merck, SAP, Sartorius, Siemens Energy und Wacker Chemie im Check

Das DeepSeek-Beben am Vortag hat der DAX relativ gut überstanden. Zwischenzeitlich drohte Deutschlands wichtigstes das Aktienbarometer die 21.000-Punkte-Marke zu testen,…

DAX trotzt KI-Beben – Aixtron, Eckert, Freenet, Merck, SAP, Sartorius, Siemens Energy und Wacker Chemie im Check

Das DeepSeek-Beben am Vortag hat der DAX relativ gut überstanden. Zwischenzeitlich drohte Deutschlands wichtigstes das Aktienbarometer die 21.000-Punkte-Marke zu testen,…

Merck Q4 Earnings Coming Up: Buy, Hold or Sell MRK Stock Now?

When Merck reports fourth-quarter earnings, investors are likely to focus on the sales of its blockbuster oncology medicine, Keytruda.…

MRKs sNDA for Welireg in Rare Tumors Gets FDAs Priority Tag

The FDA accepts and grants priority review to Mercks sNDA for Welireg to treat advanced pheochromocytoma and paraganglioma. A decision…

Merck gets priority review for Welireg for PPGL

…

Why This Beaten-Down Stock Is a Buy in 2025 and Beyond

Last year wasnt a good one for Merck (NYSE: MRK), one of the largest pharmaceutical companies in the world. The…

These Were the 5 Worst-Performing Stocks in the Dow Jones Industrial Average in 2024

The Dow Jones Industrial Average (DJIA) is a group of 30 U.S. industry leaders. Its often looked at as a…

Merck gewährt zehn Extra-Tage für Pflege Angehöriger

Der Pharma- und Technologiekonzern Merck will Beschäftigte weltweit unterstützen, wenn sie sich um schwer erkrankte Familienangehörige kümmern. Mit einem neuen…

Merck gewährt zehn Extra-Tage für Pflege Angehöriger

DARMSTADT (dpa-AFX) - Der Pharma- und Technologiekonzern Merck will Beschäftigte weltweit unterstützen, wenn sie sich um schwer erkrankte Familienangehörige kümmern.…

Pharmabranche: Merck gewährt zehn Extra-Tage für Pflege Angehöriger

Wenn Eltern, Kinder oder Partner schwer erkranken, belastet das Angehörige stark. Der Pharmakonzern führt nun global ein Programm für Mitarbeiter…

3 Unstoppable Stocks to Buy That Wall Street Thinks Will Soar More Than 35%

Just because Wall Street likes a stock doesnt mean its a great pick. However, its not a bad idea to…

Kennedy would keep legal fees from Merck cases if confirmed By Reuters

Kennedy would keep legal fees from Merck cases if confirmed…

Why Summit Therapeutics Stock Is Jumping Today

Shares of Summit Therapeutics (NASDAQ: SMMT) had jumped 14.3% at 11:31 a.m. ET on Tuesday. The nice gain came after…

Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025?

2024 was an excellent year for the major stock market indexes. But the Dow Jones Industrial Average (DJINDICES: ^DJI) had…

JPMorgan belässt Merck KGaA auf Overweight - Ziel 190 Euro

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA nach einer Medizinkonferenz mit einem Kursziel…

Earnings Season Scorecard and Fresh Analyst Reports for Chevron, Merck & Others

Todays Research Daily features a real-time update on the Q4 earnings season and fresh Chevron (CVX), Merck (MRK), QUALCOMM (QCOM),…

Is Moderna Stock a Buy?

Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index.…

Exclusive-Kennedy played key role in vaccine case against Merck By Reuters

Exclusive-Kennedy played key role in vaccine case against Merck…

Merck & Co Aktie: Kursziel gekappt

New York (www.aktiencheck.de) - Rating-Update: Vamil Divan, Analyst von Guggenheim Securities, stuft die Aktie von Merck & Co Inc. (ISIN: US58933Y1055,…

Merck Aktie: Erfolgswelle schwappt weiter!

Die Merck-Aktie zeigte am heutigen Handelstag eine volatile Entwicklung an der XETRA-Börse. Der Anteilsschein bewegte sich in einer Spanne zwischen…

This Vanguard ETF Has 23% of Its Portfolio Invested in Tech Stocks, but It Can Still Help You Generate Decades of Passive Income

The technology sector has crushed the S&P 500 over the past three, five, and 10 years as leading tech stocks…

JPMorgan belässt Merck KGaA auf Overweight - Ziel 190 Euro

NEW YORK (dpa-AFX Analyser) - JPMorgan hat die Einstufung für Merck KGaA nach einer Fachkonferenz der US-Bank mit einem Kursziel…

Merck Falls 9% in 3 Months: Buy, Hold or Sell the Stock?

We believe investors with a long-term horizon should hold MRK stock, while short-term investors should consider selling it.…

Antibody Drug Conjugates Market Outlook 2025-2035, with Forecasts for Payload Type, Linker Type, Target Antigen and Applications

Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market Report 2025-2035" has been added to…

Jim Cramer says he supports healthcare stocks for their long-term value

CNBCs Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and Regeneron.…

Merck CEO talks medicines beyond the companys top cancer drug

Merck CEO Rob Davis told CNBCs Jim Cramer that theres more to the pharmaceutical giant than its lucrative cancer drug,…

Merck & Co. Inc. (MRK) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

…

Digital Neuro Biomarkers Market Research 2025-2030, Competitive Analysis of Altoida, Koneksa, Biogen, Roche, NeuraMetrix, Merck, Linus Health, Neurotrack Technologies, Huma, and NeuraLight

The market is witnessing significant growth owing to various factors such as increased prevalence of neurological disorders, rising geriatric population…

Meet the 15 Dow Jones Stocks That Combined for Over $150 Billion in Dividends in 2024 and Will All Likely Boost Their Payouts Again in 2025

The Dow Jones Industrial Average (DJINDICES: ^DJI) is composed of 30 industry-leading blue-chip businesses that represent the broader market. Many…

Cancer Immunotherapy Global Market Overview 2023-2030, Competitive Analysis of Amgen, AstraZeneca,Bayer, BMS, Eli Lilly, F. Hoffmann-La Roche, GSK, Immunocore, J&J, Merck, Novartis, Pfizer

The global cancer immunotherapy market is primarily driven by the rising prevalence of cancer worldwide, leading to a growing demand…

Merck & Co Aktie: UBS skeptisch für BioPharma-Markt 2025 - Der Pharma-Riese trotzdem mit Potenzial

Zürich (www.aktiencheck.de) - Merck & Co-Aktienanalyse von der UBS: Aktuelle Bewertung Der UBS-Analyst, Trung Huynh, hat das Kursziel für Merck & Co…

Pfizer, Astellas win China nod for Padcev in bladder cancer with Merck’s Keytruda

…

Merck Aktie: Stabiles Wachstum zu fairem Preis

Wien (www.aktiencheck.de) - Merck-Aktienanalyse der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), rät in einer…

Merck führt erste cyber-physische Digital-Trust-Plattform für höhere Produktsicherheit und Schutz vor Produktfälschung am Markt ein

Merck: Darmstadt, Deutschland (ots/PRNewswire) - - Sichere cyber-physische Plattform M-Trust™ für vertrauenswürdigen digitalen Datenaustausch ermöglicht Erstellung digitaler Zwillinge zur Erhöhung…

Merck to buy vaccine plant from WuXi Biologics: report

…

Why Viking Therapeutics Stock Plummeted by 24% in December

Viking Therapeutics (NASDAQ: VKTX) didnt exactly capture investors hearts in the final month of 2024. The biotech companys share price…

Prediction: These 3 Healthcare Stocks Will Soar in 2025

No one knows for sure what the new year will hold for the market. However, some stocks chances for success…

Should You Buy the Dip on This High-Flying Stock?

Its been an excellent year for Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech company. Thanks to impressive mid-stage clinical results,…

Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock…

Want $2,000 in Annual Dividends? Invest $11,000 in Each of These 3 Stocks.

Investing in dividend stocks can be an excellent way to boost your income each year. But the challenge can be…

2 High-Yield Dividend Stocks to Buy Early in 2025

The healthcare sector has long been a sanctuary for income investors seeking stability and growth. Within this realm, Bristol-Myers Squibb…

Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?

Stocks splits have been a huge market theme in 2024, with big names across industries, from technology giant Nvidia to…

3 Stocks That Could Be Monster Winners in 2025

What do many kids like most about the coming of a new year? The fireworks. Investors dont mind seeing some…

These stocks will be the biggest Dow winners of 2025, according to analysts

Some favorites of the Dow Jones Industrial Average, including Nvidia and Merck, could surge next year.…

2 Reasons to Sell Merck Stock and 1 Reason to Buy

There is plenty to like about Merck (NYSE: MRK). It is one of the largest pharmaceutical companies and the owner…

Merck - Selten so attraktiv

Mit strategischen Zukäufen treibt die deutsche Merck ihr geplantes Wachstum zielgerichtet voran. Die Anleger zeigen sich zuletzt aber skeptisch -…